期刊文献+

冠心病合并2型糖尿病冠状动脉造影特点分析 被引量:6

下载PDF
导出
摘要 目的探讨冠心病合并2型糖尿病患者的冠脉造影特点。方法入选2006年1~12月经冠脉造影确诊的冠心病患者621例,其中166例合并2型糖尿病(I组),不合并2型糖尿病的患者455例(Ⅱ组)。收集并分析患者的临床和冠脉造影资料。结果与Ⅱ组比较,Ⅰ组多支病变和弥漫病变的发生率多于Ⅱ组(P〈0.01)。入选患者中213例呈冠脉弥漫性病变,其中83例合并2型糖尿病(Ⅲ组),余130例为不合并糖尿病(Ⅳ组)。Ⅲ组弥漫性三支病变和全程弥漫性病变的发生率显著高于Ⅳ组(P〈0.05)。结论冠心病合并2型糖尿病时冠脉病变范围更广,程度更严重。因此对糖尿病患者严格积极地控制血糖、干预血压和血脂等危险因素,有助于预防冠脉弥漫复杂病变的发生和改善预后。
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2008年第9期1196-1197,共2页 Journal of Shanghai Jiao tong University:Medical Science
  • 相关文献

参考文献10

  • 1中国心脏调查组,胡大一,潘长玉.中国住院冠心病患者糖代谢异常研究——中国心脏调查[J].中华内分泌代谢杂志,2006,22(1):7-10. 被引量:470
  • 2Burke AP, Kolodgie FD, Zieske A,et al. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study [J]. Arterioscler Thromb Vasc Biol, 2004,24(7) :1266 - 1271.
  • 3Natali A, Vichi S, Landi P, et al. Coronary atherosclerosis in Type Ⅱ diabetes: angiographic findings and clinical outcome[ J]. Diabetologia, 2000,43 ( 5 ) :632 - 641.
  • 4Takaishi H, Taniguchi T, Fujioka Y, et al. Impact of increasing diabetes on coronary artery disease in the past decade[ J]. J Atheroscler Thromb, 2004,11 (5) :271 -277.
  • 5ACC/AHA Task Force. Guidelines for percutaneous transluminal coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures ( Subcommittee on Percutaneous Transluminal Coronary Angioplasty) [J]. J Am Coll Cardiot, 1988,12(2) :529-545.
  • 6Johansen OE, Birkeland KI. Preventing macrovascular disease in patients with type 2 diabetes mellitus[ J]. Am J Cardiovasc Drugs, 2003,3(4) :283 -297.
  • 7Deedwania PC. Mechanisms of endothelial dysfunction in themetabolicsyndrome [ J ]. Curr Diab Rep, 2003, 3 (4) : 289 - 292.
  • 8Goldin A, Beckman JA, Schmidt AM, et al. Advanced glycation end products: sparking the development of diabetic vascular injury [ J ]. Circulation,2006,114 (6) :597 - 605.
  • 9Fonseca V, Desouza C, Asnani S, et al. Nontraditional risk factors for cardiovascular disease in diabetes [ J ]. Endocrine Reviews, 2004, 25(1) :153 -175.
  • 10高妍.糖尿病与心血管疾病[J].中华内分泌代谢杂志,2005,21(5). 被引量:14

二级参考文献21

  • 1李素青,田玉华,朱敏,杨超元.中老年糖尿病流行病学调查方法探讨[J].实用老年医学,1996,10(4):175-176. 被引量:13
  • 2Fonseca V, Desouza C, Asnani S, et al. Nontraditional risk factors for cardiovascular disease in diabetes. Endocr Rev, 2004,25:153-175.
  • 3Wong ND, Kawakubo M, LaBree L, et al. Relation of coronary calcium progression and control of lipids according to National Cholesterol Education Program guidelines. Am J Cardiol, 2004,94:431-436.
  • 4Tuomilehto J. Reducing coronary heart disease associated with type 2 diabetes: lifestyle intervention and treatment of dyslipidaemia. Diabetes Res Clin Pract, 2003,61(Suppl 1):S27-S34.
  • 5Deedwania PC, Hunninghake DB, Bays H. Effects of lipid-altering treatment in diabetes mellitus and the metabolic syndrome. Am J Cardiol, 2004,93(Suppl 1):18-26.
  • 6Brown WV. Managing dyslipidaemia multiple patients and multiple approaches: metabolic syndrome, familial hypercholesterolaemia and hypertension. Eur Heart J, 2004,6(Suppl A):A23-A27.
  • 7Aljada A, Ghanim H, Mohanty P, et al. Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1(PAI-1) concentrations. J Clin Endocrinol Metab, 2002,87:1419-1422.
  • 8Haffner SM. Insulin resistance, inflammation, and the prediabetic state. Am J Cardiol, 2003,92(Suppl 1):18-26.
  • 9Brown AS. Lipid management in patients with diabetes mellitus. Am J Cardiol, 2005,96(Suppl):26-32.
  • 10King H,Aubert RE,Herman WH.Global burden of diabetes 1995-2025.Prevalence,numerical estimates and projections.Diabetes Care,1998,21:1414-1431.

共引文献480

同被引文献36

  • 1陈劲松,杨希立,栾晓军,胡利东,梁明,李健民,肖长华.2型糖尿病合并冠心病患者的脂代谢和冠状动脉造影分析[J].中华糖尿病杂志(1006-6187),2005,13(3):226-227. 被引量:16
  • 2孙雪岩,贾大林,齐国先.血压与冠状动脉造影病变的关系[J].中国动脉硬化杂志,2006,14(10):895-898. 被引量:4
  • 3桂明辉,洪洁,吕安康,顾卫琼,张翼飞,陈瑛,孙海燕,吴荔茗,沈卫峰,王卫庆,李小英,宁光.2型糖尿病冠心病患者的临床及冠状动脉造影特点[J].中华内分泌代谢杂志,2007,23(2):122-125. 被引量:20
  • 4Gillum RF, Mussolino ME, Madans JH. Diabetes mellitus, coronary heart disease incidence and death from all causes in African American and European American women:the NHANES I epidemiologic follow-up study. Clin Epidemiol,2000,53 (5) :511-518.
  • 5Uddin SN,Malik F, Bail MA, et al. Angiographie severity and extent of coronary artery disease in patients with type 2 diabetes mellitus. Mymensingh Med J,2005,14 ( 1 ) :32-37.
  • 6Kaur J, Singh P, Sowers JR. Diabetes and cardiovascular disease. Am J Trher,2002,9(6) :510-515.
  • 7Deedwania PC. Mechanisms of endothelial dysfunction in the metabolic syndrome. Curr Diab Rep 12003,3 (4) :289-292.
  • 8Luo N, Liu J, Chung BH, et al. Macrophage adiponec- tin expression improves insulin sensitivity and protects against inflammation and atherosclerosis [ J]. Diabetes, 2010,59(4) :791-9.
  • 9Ruggiero C, Cherubini A, Ble A, et al. Uric acid and in- flammatory markers [ J ]. Eur Heart J, 2006,27 ( ! 0 ) ~ 1174-1181.
  • 10ACC/AHA Task Force. Guidelines for percutaneous transluminal coronary angiography. A reporl of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty) [J]. J Am Coll Cardiol, 1988,12(2) :529 - 545.

引证文献6

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部